The efficacy and safety of omalizumab in the treatment of asthma: an overview of systematic reviews and meta analyses

Authors

Institutions

Publication Details

Journal
Frontiers in Medicine
Published
2026-01-16
DOI
https://doi.org/10.3389/fmed.2025.1755023
Primary Topic
Asthma and respiratory diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The efficacy and safety of omalizumab in the treatment of asthma: an overview of systematic reviews and meta analyses

Dongze Li, Yinan Guo, Yongji Wang, Bo Tian et al.
Frontiers in Medicine
Asthma and respiratory diseases
article

The efficacy and safety of omalizumab in the treatment of asthma: an overview of systematic reviews and meta analyses

Dongze Li, Yinan Guo, Yongji Wang, Bo Tian, Xiaofei Xie, Zhuang Wang, Na Wang, Lijie Hou
article en

Abstract

No abstract available for this paper.
Frontiers in MedicineVol. 12
Changchun University of Chinese Medicine (CN), The Affiliated Hospital to Changchun University of Chinese Medicine (CN)
Good health and well-being
Openalex Percentile: Top 87%
Asthma and respiratory diseases
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

The efficacy and safety of omalizumab in the treatment of asthma: an overview of systematic reviews and meta analyses — Dongze Li, Yinan Guo, et al. · Frontiers in Medicine (2026) | TGRS Research Map | TGRS